Hostname: page-component-5db58dd55d-m58mf Total loading time: 0 Render date: 2026-06-17T12:45:39.817Z Has data issue: false hasContentIssue false
  • English
  • Français

Hospital-Onset Clostridium difficile Infection Rates in Persons with Cancer or Hematopoietic Stem Cell Transplant: A C3IC Network Report

Published online by Cambridge University Press:  02 January 2015

Mini Kamboj ,
Crystal Son ,
Sherry Cantu ,
Roy F. Chemaly ,
Jeanne Dickman ,
Erik Dubberke ,
Lisa Engles ,
Theresa Lafferty ,
Gale Liddell  and
Mary Ellen Lesperance
...Show all authors
Mini Kamboj*
Affiliation:
Memorial Sloan Kettering Cancer Center, New York, New York
Crystal Son
Affiliation:
Memorial Sloan Kettering Cancer Center, New York, New York
Sherry Cantu
Affiliation:
MD Anderson Cancer Center, Houston, Texas
Roy F. Chemaly
Affiliation:
MD Anderson Cancer Center, Houston, Texas
Jeanne Dickman
Affiliation:
James Cancer Hospital at Ohio State University Medical Center, Columbus, Ohio
Erik Dubberke
Affiliation:
Barnes-Jewish Hospital, Siteman Cancer Center, St. Louis, Missouri Washington University School of Medicine, St. Louis, Missouri
Lisa Engles
Affiliation:
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan
Theresa Lafferty
Affiliation:
Fox Chase Cancer Center, Philadelphia, Pennsylvania
Gale Liddell
Affiliation:
Roswell Park Cancer Institute, Buffalo, New York
Mary Ellen Lesperance
Affiliation:
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan
Julie E. Mangino
Affiliation:
James Cancer Hospital at Ohio State University Medical Center, Columbus, Ohio
Stacy Martin
Affiliation:
Moffitt Cancer Center, Tampa, Florida
Jennie Mayfield
Affiliation:
Barnes-Jewish Hospital, Siteman Cancer Center, St. Louis, Missouri
Sapna A. Mehta
Affiliation:
NYU Langone Medical Center, New York, New York
Susan O'Rourke
Affiliation:
Dana-Farber Cancer Institute, Boston, Massachusetts
Cheryl S. Perego
Affiliation:
MD Anderson Cancer Center, Houston, Texas
Randy Taplitz
Affiliation:
Thornton Hospital, UCSD, La Jolla, California
Janet Eagan
Affiliation:
Memorial Sloan Kettering Cancer Center, New York, New York
Kent A. Sepkowitz
Affiliation:
Memorial Sloan Kettering Cancer Center, New York, New York
*
1275 York Avenue, New York, NY 10065 (kambojm@mskcc.org)
Get access Rights & Permissions [Opens in a new window]

Abstract

A multicenter survey of 11 cancer centers was performed to determine the rate of hospital-onset Clostridium difficile infection (HO-CDI) and surveillance practices. Pooled rates of HO-CDI in patients with cancer were twice the rates reported for all US patients (15.8 vs 7.4 per 10,000 patient-days). Rates were elevated regardless of diagnostic test used.

Information

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 33 , Issue 11 , November 2012 , pp. 1162 - 1165
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.American Cancer Society. http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2011.Google Scholar
2.Anand, A, Glatt, AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 1993;17(1):109–113.Google Scholar
3.Gorschluter, M, Glasmacher, A, Hahn, C, et al.Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 2001;33(6):786–791.CrossRefGoogle ScholarPubMed
4.Loo, VG, Poirier, L, Miller, MA, et al.A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353(23):2442–2449.Google Scholar
5.Bobak, D, Arfons, LM, Creger, RJ, Lazarus, HM. Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplantation 2008;42(11):705–713.Google Scholar
6.McDonald, LC, Coignard, B, Dubberke, E, et al.Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28(2):140–145.Google Scholar
7.New York State Department of Health. http://www.health.ny.gov/statistics/facilities/hospital/hospital_acquired_infections/2010/docs/hospital_acquired_infection.pdf.Google Scholar
8.California Department of Public Health. http://www.cdph.ca.gov/programs/hai/Pages/CDI-Report.aspx.Google Scholar
9.Ohio Department of Public Health. http://www.odh.ohio.gov/~/media/ODH/ASSETS/Files/news/cdiffnnalreport.ashx.Google Scholar
10.Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012;61:157–162.Google Scholar
11.Deshpande, A, Pasupuleti, V, Rolston, DD, et al.Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis. Clin Infect Dis 2011;53(7):e81–e90.Google Scholar
12.Fong, KS, Fatica, C, Hall, G, et al.Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level? Infect Control Hosp Epidemiol 2011;32(9):932–933.Google Scholar
13.Kaltsas, A, Simon, M, Unruh, LH, et al.Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results. J Clinical Microbiol 2012:50(4):1303–1307.Google Scholar